Ozempic and Mounjaro are brand names of the 'GLP-1 receptor agonist' class of medicines, which help one manage diabetes and obesity by targeting appetite and enhancing satiety, resulting in a significant weight loss and cardiovascular benefits.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/mnO23Rf
via gqrds
No comments:
Post a Comment